Comparative Pharmacology
Head-to-head clinical analysis: M V I ADULT versus MVC PLUS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I ADULT versus MVC PLUS.
M.V.I. ADULT vs MVC PLUS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Multivitamin preparation providing essential vitamins (A, D, E, K, C, B1, B2, B3, B5, B6, B12, biotin, folic acid) as cofactors for various metabolic reactions, including energy production, collagen synthesis, antioxidant defense, and blood coagulation.
MVC PLUS is a fixed-dose combination of maraviroc, a CCR5 co-receptor antagonist, and lamivudine, a nucleoside reverse transcriptase inhibitor. Maraviroc binds to CCR5 on CD4+ T cells blocking HIV-1 entry; lamivudine inhibits HIV reverse transcriptase via competitive inhibition and chain termination.
10 mL intravenously as a single daily dose, administered as an infusion over at least 2 hours. For patients with documented deficiency, dose may be repeated. Route: IV.
10 mg orally once daily.
None Documented
None Documented
Highly variable by component; e.g., ascorbic acid: 8-40 days (depletion), thiamine: 9-18 days, pyridoxine: 2-3 weeks, fat-soluble vitamins: vitamin A: 2-3 months (liver stores), vitamin D: 15-25 days, alpha-tocopherol: 17-19 days, vitamin K: 2-3 hours (short). Clinical context: half-life reflects tissue storage and turnover; chronic dosing leads to accumulation for fat-soluble vitamins.
Terminal elimination half-life: 12-18 hours (mean 14 hours). Clinically, this supports twice-daily dosing with steady-state achieved in ~3 days.
Renal: water-soluble vitamins (B-complex, C) are primarily excreted unchanged in urine; fat-soluble vitamins (A, D, E, K) are excreted in feces via bile. % varies by vitamin: e.g., thiamine 40-60% renal, ascorbic acid 50% renal; vitamin A >80% fecal.
Renal: ~70% unchanged; Fecal: ~25%; Biliary: <5%
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement